|
|
2023's Stock Market Performance
|
|
2023's Stock Market Performance
|
2023's Large Cap Stocks Performance
Here are the best and worst performing Large-Cap Stocks of 2023.
The Large-Cap Company is defined with the market capitalization, trading above 5 billion dollars U.S. as of 10/01/26.
2023's Mid Cap Stocks Performance
Here are the best and worst performing companies of 2023 with the market capitalization, trading between 500 million U.S. dollars and 5 billion dollars U.S. respectively, as of 10/01/26.
2023's Small Cap Stocks Performance
The table shows the best and worst performing companies of 2023 with the market capitalization, trading between 50 million U.S. dollars and 500 million dollars U.S. respectively, as of 10/01/26.
2023's Micro Cap Stocks Performance
The list shows the best and worst performing companies of 2023 with the market capitalization, trading under 50 million U.S. dollars, as of 10/01/26.
Who are the 2023's Stock Market Winners?
IMMX
+211.71%
|
|
|
Immix Biopharma Inc
Major Pharmaceutical Preparations Industry
IMMX
+211.71%
ImmIx Biopharma Inc is a biotechnology company that focuses on developing novel therapeutics for the treatment of cancer. Their business model involves conducting extensive research and development to discover and optimize drug candidates, followed by preclinical and clinical testing to assess their safety and effectiveness. They aim to collaborate with pharmaceutical companies or seek licensing agreements to further develop and commercialize their biopharmaceutical products.
|
DERM
+213.04%
|
|
|
Journey Medical Corp
Major Pharmaceutical Preparations Industry
DERM
+213.04%
Journey Medical Corporation is a pharmaceutical and medical device company that specializes in developing and commercializing innovative products for dermatology and aesthetics. Their business model revolves around conducting research and development to create new products, acquiring the necessary regulatory approvals, and partnering with healthcare professionals to effectively distribute and market these products. By focusing on dermatology and aesthetics, Journey Medical Corporation aims to address unmet medical needs and provide cutting-edge solutions to improve patient outcomes in these fields.
|
GEOS
+222.39%
|
|
|
Geospace Technologies Corp
Scientific & Technical Instruments Industry
GEOS
+222.39%
Geospace Technologies Corp operates within the oil and gas industry, specializing in manufacturing seismic instruments used for data acquisition. The company*s business model revolves around designing, developing, and selling advanced technology products, predominantly consisting of seismic data acquisition systems, reservoir characterization products, and related services. Geospace Technologies Corp focuses on providing innovative solutions to its customers to enhance their exploration and production capabilities in the global energy market.
|
INZY
+227.69%
|
|
|
Inozyme Pharma Inc
Major Pharmaceutical Preparations Industry
INZY
+227.69%
Inozyme Pharma Inc is a biopharmaceutical company that focuses on developing and commercializing novel therapies for the treatment of rare and life-threatening mineral metabolic disorders. The company aims to leverage its expertise in the biology of enzymes and rare diseases to develop innovative therapeutics that can address the underlying cause of these disorders. Inozyme Pharma pursues partnerships and collaborations to advance their pipeline of potential therapies and bring them to market efficiently.
|
ELTK
+228.24%
|
|
|
Eltek Ltd
Semiconductors Industry
ELTK
+228.24%
Eltek Ltd operates on a business model that focuses on providing innovative and reliable power solutions for a wide range of industries. The company designs, manufactures, and supplies advanced power conversion systems and solutions tailored to meet the specific needs of its customers. Through a combination of engineering expertise and efficient manufacturing processes, Eltek Ltd aims to deliver high-quality products and services that ensure the efficient and uninterrupted operation of critical equipment and systems.
|
SKYH
+238.95%
|
|
|
Sky Harbour Group Corporation
Real Estate Operations Industry
SKYH
+238.95%
Sky Harbour Group Corporation operates as a diversified holding company with a focus on acquiring, managing, and growing businesses across various industries. They aim to create long-term value for their shareholders by capitalizing on opportunities that offer significant growth potential and strategic advantages. With a well-rounded portfolio and a disciplined investment approach, Sky Harbour Group Corporation aims to drive profitability and maximize returns for its stakeholders.
|
BCHT
+240.74%
|
|
|
Birchtech Corp
Scientific & Technical Instruments Industry
BCHT
+240.74%
Birchtech Corp. specializes in activated carbon technologies used for air and water purification.
|
HRTG
+252.43%
|
|
|
Heritage Insurance Holdings Inc
Property & Casualty Insurance Industry
HRTG
+252.43%
Heritage Insurance Holdings Inc operates as a property and casualty insurance company that provides personal and commercial residential insurance products through a network of independent agents. The company earns revenue by collecting premiums from policyholders and paying out claims for covered losses.
|
NTPIF
+257.14%
|
|
|
Nam Tai Property Inc
Real Estate Operations Industry
NTPIF
+257.14%
Nam Tai Property Inc. operates primarily in the real estate market in China, focusing on property development.
|
AUGX
+276.21%
|
|
|
Augmedix Inc
Professional Services Industry
AUGX
+276.21%
Augmedix Inc*s business model is centered around providing medical professionals with a remote scribe service. They utilize a combination of wearable technology and real-time documentation software to assist healthcare providers in generating accurate and comprehensive medical documentation during patient consultations.
|
CASIF
+289.13%
|
|
|
Casi Pharmaceuticals inc
Major Pharmaceutical Preparations Industry
CASIF
+289.13%
CASI Pharmaceuticals, Inc. and its subsidiaries operate in pharmaceutical development and manufacturing.
|
NERV
+307.28%
|
|
|
Minerva Neurosciences Inc
Major Pharmaceutical Preparations Industry
NERV
+307.28%
Minerva Neurosciences Inc is a biopharmaceutical company that primarily focuses on the development and commercialization of innovative therapies for central nervous system disorders. They aim to identify potential drug candidates, conduct clinical trials, and collaborate with partners to bring novel treatments to market.
|
APTO
+323.33%
|
|
|
Aptose Biosciences Inc
Biotechnology & Pharmaceuticals Industry
APTO
+323.33%
Aptose Biosciences Inc has a business model focused on developing and commercializing targeted therapies for the treatment of various types of cancers. This involves conducting research, preclinical and clinical development activities, and eventually partnering or licensing their drug candidates to pharmaceutical companies for further development and commercialization.
|
MPTI
+327.03%
|
|
|
M tron Industries Inc
IT Infrastructure Industry
MPTI
+327.03%
M Tron Industries Inc*s business model revolves around the manufacturing and distribution of industrial electronic components and systems.
|
LFMD
+338.62%
|
|
|
Lifemd Inc
Healthcare Facilities Industry
LFMD
+338.62%
Lifemd Inc*s business model involves providing healthcare services and solutions through technology and telemedicine platforms.
|
SERA
+356.49%
|
|
|
Sera Prognostics Inc
Medical Laboratories Industry
SERA
+356.49%
Sera Prognostics Inc has a business model that focuses on developing and commercializing innovative diagnostic tests for predicting pregnancy complications.
|
|